The Goldman Sachs Group Cuts Teladoc Health (NYSE:TDOC) Price Target to $55.00

Teladoc Health (NYSE:TDOCGet Rating) had its price target decreased by The Goldman Sachs Group from $77.00 to $55.00 in a research note issued to investors on Thursday morning, Stock Target Advisor reports. The Goldman Sachs Group currently has a buy rating on the health services provider’s stock.

A number of other analysts have also commented on TDOC. Guggenheim lowered Teladoc Health from a buy rating to a neutral rating in a report on Thursday, April 28th. UBS Group dropped their price target on Teladoc Health from $130.00 to $72.00 and set a neutral rating on the stock in a report on Tuesday, March 8th. Credit Suisse Group lowered Teladoc Health from an outperform rating to a neutral rating and dropped their price target for the stock from $114.00 to $35.00 in a report on Thursday, April 28th. Stifel Nicolaus dropped their price target on Teladoc Health from $83.00 to $74.00 and set a hold rating on the stock in a report on Wednesday, February 23rd. Finally, Canaccord Genuity Group dropped their price target on Teladoc Health from $112.00 to $50.00 in a report on Thursday, April 28th. One investment analyst has rated the stock with a sell rating, eighteen have assigned a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, Teladoc Health presently has an average rating of Hold and a consensus target price of $88.36.

TDOC stock opened at $35.77 on Thursday. Teladoc Health has a twelve month low of $27.38 and a twelve month high of $174.32. The company has a quick ratio of 3.71, a current ratio of 3.94 and a debt-to-equity ratio of 0.17. The stock’s 50 day moving average is $51.97 and its 200-day moving average is $73.24. The firm has a market capitalization of $5.77 billion, a PE ratio of -0.83 and a beta of 0.82.

Teladoc Health (NYSE:TDOCGet Rating) last posted its earnings results on Wednesday, April 27th. The health services provider reported ($41.58) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.58) by ($41.00). Teladoc Health had a negative net margin of 321.94% and a negative return on equity of 2.12%. During the same period in the prior year, the business posted $0.13 earnings per share. On average, equities research analysts anticipate that Teladoc Health will post -2 earnings per share for the current fiscal year.

In related news, insider Adam C. Vandervoort sold 3,513 shares of the business’s stock in a transaction dated Thursday, March 3rd. The stock was sold at an average price of $70.24, for a total transaction of $246,753.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Andrew Turitz sold 1,754 shares of the business’s stock in a transaction dated Thursday, March 3rd. The stock was sold at an average price of $70.24, for a total value of $123,200.96. The disclosure for this sale can be found here. Over the last quarter, insiders sold 14,842 shares of company stock valued at $1,042,502. 1.55% of the stock is owned by company insiders.

A number of institutional investors have recently bought and sold shares of TDOC. Altshuler Shaham Ltd lifted its stake in Teladoc Health by 15.4% during the third quarter. Altshuler Shaham Ltd now owns 750 shares of the health services provider’s stock worth $95,000 after purchasing an additional 100 shares during the last quarter. First Mercantile Trust Co. lifted its stake in Teladoc Health by 1.1% during the third quarter. First Mercantile Trust Co. now owns 9,550 shares of the health services provider’s stock worth $1,211,000 after purchasing an additional 100 shares during the last quarter. Personal CFO Solutions LLC lifted its stake in Teladoc Health by 4.5% during the third quarter. Personal CFO Solutions LLC now owns 2,531 shares of the health services provider’s stock worth $321,000 after purchasing an additional 110 shares during the last quarter. The Manufacturers Life Insurance Company lifted its stake in Teladoc Health by 5.2% during the fourth quarter. The Manufacturers Life Insurance Company now owns 2,766 shares of the health services provider’s stock worth $254,000 after purchasing an additional 137 shares during the last quarter. Finally, Benjamin Edwards Inc. lifted its stake in Teladoc Health by 27.6% during the fourth quarter. Benjamin Edwards Inc. now owns 670 shares of the health services provider’s stock worth $62,000 after purchasing an additional 145 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Teladoc Health Company Profile (Get Rating)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.

Featured Stories

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.